Pharmacological stress agents for evaluation of ischemic heart disease.
Ischemic heart disease is the leading cause of death in the developed countries for those older than 65 years of age. In patients suspected to have coronary artery disease a stress test should be performed to identify the vulnerability of the myocardium to ischemia. As a rule of thumb, the evaluation of coronary artery disease is best done by exercise stress test. In patients who are not able to exercise adequately, pharmacological stress agents are used. The commonly used agents are the coronary vasodilators, adenosine and dipyridamole and the catecholamines, dobutamine and arbutamine. These agents are combined with imaging techniques to increase the sensitivity and specificity of the test. These agents have been widely used and have an excellent safety profile. Another advantage in using pharmacological stress agents is that they do not affect the image quality, especially with echocardiography and magnetic resonance imaging. Ongoing developments hold promise for safer and more reliable pharmacological stress agents in the future.
Ali Raza
J
J
Section of Cardiology, Department of Medicine, East Carolina University School of Medicine, Greenville, NC 27834-4354, USA.
Reeves
W C
WC
Movahed
A
A
D000318:Adrenergic beta-Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D002395:Catecholamines / Q000494:pharmacology / Q000627:therapeutic use; D003952:Diagnostic Imaging; D004280:Dobutamine / Q000494:pharmacology / Q000627:therapeutic use; D005080:Exercise Test; D005544:Forecasting; D006801:Humans; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D014665:Vasodilator Agents; D004280:Dobutamine; C076559:arbutamine